“Bimekizumab Impact on Pain in Moderate to Severe Hidradenitis Suppurativa: Week 16 Results from BE HEARD I & II”, J of Skin, vol. 8, no. 1, p. s350, Jan. 2024, doi: 10.25251/skin.8.supp.350.